NCT07588698
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07588698
Title Epcoritamab in Combination With R-CHOP for Patients With Aggressive Non-Hodgkin Lymphoma
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Mwanasha Merrill, MD
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Zuckerberg San Francisco General San Francisco California 94110 United States Details
University of California, San Francisco San Francisco California 94143 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field